{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"LCTC","limit":50},"count":50,"signals":[{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":100,"match_count":31,"context":"nt of our invoices by government payment offices. These and other factors could cause government customers or our distributors to reduce purchases of products and services from us, which would have a material adverse effect on our business, financial condition and operating results. **** **** | 11 | | | | | **Third parties may infringe on our patents, and as a result, we could incur significant expense in protecting our","filed_date":"2026-03-27","accession":"0001079973-26-000376","full_text":"https://origin.rootz.global/static/filing/0001079973-26-000376.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":100,"match_count":72,"context":"fication or license necessary, except where the failure to be so qualified or licensed or to be in good standing, would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.  | 6 | | | | | (b) Charter Documents. The Company is a corporation duly organized, validly existing and in good standing under the Laws of the state of Washington and has full corporate power and au","filed_date":"2025-10-15","accession":"0001079973-25-001607","full_text":"https://origin.rootz.global/static/filing/0001079973-25-001607.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":15,"context":"ecke(1) | |  85 | | |  Non-Management Director | | |  Michael J. Kornelsen, D.M.A. | |  64 | | |  Non-Management Director | | |  (1) | Member of the Audit Committee | | **Wayne Willkomm, Ph.D.**, was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2025-04-18","accession":"0001079973-25-000678","full_text":"https://origin.rootz.global/static/filing/0001079973-25-000678.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":100,"match_count":22,"context":"ured components and global supply chains, and any increase in tariffs or trade restrictions may force us to seek alternative suppliers, renegotiate pricing, or absorb higher costs, which could have a material adverse effect on our financial condition and results of operations. As the political landscape evolves, we may need to adjust our strategies to comply with new regulatory and trade policies, which could result in","filed_date":"2025-03-28","accession":"0001079973-25-000507","full_text":"https://origin.rootz.global/static/filing/0001079973-25-000507.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":14,"context":"Donald E. Siecke(1) |  |  84 |  |  Non-Management Director | | |  Michael J. Kornelsen, D.M.A. |  |  63 |  |  Non-Management Director | | (1) Member of the Audit Committee *Wayne Willkomm, Ph.D.,*was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2024-04-24","accession":"0001079973-24-000587","full_text":"https://origin.rootz.global/static/filing/0001079973-24-000587.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":100,"match_count":13,"context":"ve, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay or abandon research and development plans. In addition, there is a risk that one or more of our current sup","filed_date":"2024-04-01","accession":"0001079973-24-000474","full_text":"https://origin.rootz.global/static/filing/0001079973-24-000474.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":19,"context":"ratify the appointment of Gries & Associates, PC as our independent public accountants for the year ending December 31, 2023; 3. To hold a non-binding advisory vote to approve the compensation of our named executive officers (Say on Pay); 4. To hold a non-binding advisory vote on the frequency of future Say on Pay votes; and 5. To transact such other business as may properly come before the meeting, or any adjournment t","filed_date":"2023-04-12","accession":"0001079973-23-000477","full_text":"https://origin.rootz.global/static/filing/0001079973-23-000477.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":18,"context":"cted and qualified; | | |  | 2. | To ratify the appointment of Causey Demgen & Moore P.C. as our independent public accountants; | | |  | 3. | To approve on an advisory basis, the compensation of our named executive officers (Say on Pay); and | | |  | 4. | To transact such other business as may properly come before the meeting, or any adjournment thereof. | | All shareholders are cordially invited to attend the meeting,","filed_date":"2020-04-02","accession":"0001079973-20-000252","full_text":"https://origin.rootz.global/static/filing/0001079973-20-000252.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":19,"context":"ted and qualified; |  | |  2. |  To ratify the appointment of Causey Demgen & Moore P.C. as our independent public accountants; |  | |  3. |  To approve, on an advisory basis, the compensation of our named executive officers (\"Say on Pay\"); and |  | |  4. |  To transact such other business as may properly come before the meeting, or any adjournment thereof. |  | All shareholders are cordially invited to attend the meeti","filed_date":"2017-04-03","accession":"0001079973-17-000212","full_text":"https://origin.rootz.global/static/filing/0001079973-17-000212.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":21,"context":"atement: |  1. |  To elect five directors to serve for a term of one year and until their successors are elected and qualified; |  | |  2. |  To approve, on an advisory basis, the compensation of our named executive officers (Say on Pay); |  | |  3. |  To vote, on an advisory basis, on the frequency of future Say on Pay votes; |  | |  4. |  To ratify the appointment of Eide Bailly LLP as our independent public accountan","filed_date":"2014-04-01","accession":"0001079973-14-000241","full_text":"https://origin.rootz.global/static/filing/0001079973-14-000241.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":13,"context":"ment Director |  | |  Wayne Willkomm |  |  50 |  |  Non-Management Director |  | (1) Member of the Audit Committee Barry R. Knott joined the Company on February 1, 2009 as our Marketing Director, was appointed to our board of directors on June 11, 2009 and became Chief Operating Officer on July 1, 2009. He became our President on October 1, 2009, and assumed the role of President and Chief Executive Officer on January 1, 2010. He","filed_date":"2013-03-21","accession":"0001079973-13-000196","full_text":"https://origin.rootz.global/static/filing/0001079973-13-000196.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":14,"context":"esigned as our Chief Executive Officer, but remains as a director. BIOGRAPHIES OF EXECUTIVE OFFICERS AND DIRECTORS Barry R. Knott joined the Company on February 1, 2009 as its Marketing Director, was appointed to the board of directors on June 11, 2009 and became chief operating officer on July 1, 2009.He became our President on October 1, 2009, and assumed the role of President and Chief Executive Officer on January 1, 2010.He ha","filed_date":"2010-11-09","accession":"0001079973-10-001181","full_text":"https://origin.rootz.global/static/filing/0001079973-10-001181.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":100,"match_count":14,"context":"esigned as our Chief Executive Officer, but remains as a director. BIOGRAPHIES OF EXECUTIVE OFFICERS AND DIRECTORS Barry R. Knott joined the Company on February 1, 2009 as its Marketing Director, was appointed to the board of directors on June 11, 2009 and became chief operating officer on July 1, 2009.He became our President on October 1, 2009, and assumed the role of President and Chief Executive Officer on January 1, 2010.He ha","filed_date":"2010-06-21","accession":"0001079973-10-000707","full_text":"https://origin.rootz.global/static/filing/0001079973-10-000707.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":93,"match_count":6,"context":"d also result in continued social, economic, and labor instability in the countries in which we or our customers and suppliers operate. These disruptions or the uncertainties around them could have a material adverse effect on our business and our results of operation and financial condition.* * **Risks Related to Our Stock** **Shares of our common stock lack a significant trading market.** Shares of our common stock ar","filed_date":"2021-03-31","accession":"0001079973-21-000200","full_text":"https://origin.rootz.global/static/filing/0001079973-21-000200.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":93,"match_count":6,"context":"ealth concerns, such as coronavirus, could also result in social, economic, and labor instability in the countries in which we or our customers and suppliers operate. These uncertainties could have a material adverse effect on our business and our results of operation and financial condition. * * **Risks Related to Our Stock** **Shares of our common stock lack a significant trading market.** Shares of our common stock a","filed_date":"2020-03-24","accession":"0001079973-20-000208","full_text":"https://origin.rootz.global/static/filing/0001079973-20-000208.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":88,"match_count":6,"context":"results in greater continued social, economic, and labor instability in the countries in which we or our customers and suppliers operate. These disruptions or the uncertainties around them have had a material adverse effect on our business and our results of operation and financial condition. ** **Risks Related to Our Stock** **Shares of our common stock lack a significant trading market.** Shares of our common stock ar","filed_date":"2023-03-14","accession":"0001079973-23-000333","full_text":"https://origin.rootz.global/static/filing/0001079973-23-000333.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":88,"match_count":11,"context":"ald E. Siecke(1) |  |  82 |  |  Non-Management Director | | |  Michael J. Kornelsen, D.M.A.(1) |  |  61 |  |  Non-Management Director | | (1) Member of the Audit Committee *Wayne Willkomm, Ph.D.,*was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2022-04-25","accession":"0001079973-22-000490","full_text":"https://origin.rootz.global/static/filing/0001079973-22-000490.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":88,"match_count":6,"context":"results in greater continued social, economic, and labor instability in the countries in which we or our customers and suppliers operate. These disruptions or the uncertainties around them have had a material adverse effect on our business and our results of operation and financial condition. ** **Risks Related to Our Stock** **Shares of our common stock lack a significant trading market.** Shares of our common stock ar","filed_date":"2022-03-03","accession":"0001079973-22-000202","full_text":"https://origin.rootz.global/static/filing/0001079973-22-000202.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":88,"match_count":11,"context":"ald E. Siecke(1) |  |  81 |  |  Non-Management Director | | |  Michael J. Kornelsen, D.M.A.(1) |  |  60 |  |  Non-Management Director | | (1) Member of the Audit Committee *Wayne Willkomm, Ph.D.,*was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale.  On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2021-04-01","accession":"0001079973-21-000223","full_text":"https://origin.rootz.global/static/filing/0001079973-21-000223.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":88,"match_count":11,"context":"or |  | |  Donald E. Siecke(1) |  |  76 |  |  Non-Management Director |  | |  Barry R. Knott |  |  60 |  |  Non-Management Director |  | (1) Member of the Audit Committee 2 Wayne Willkomm, Ph.D., was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2016-03-30","accession":"0001079973-16-000887","full_text":"https://origin.rootz.global/static/filing/0001079973-16-000887.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":88,"match_count":11,"context":"Director |  | |  Wayne Willkomm(1) |  |  52 |  |  Non-Management Director |  | (1) Member of the Audit Committee 2 Barry R. Knott joined the Company on February 1, 2009 as our Marketing Director, was appointed to our board of directors on June 11, 2009 and became Chief Operating Officer on July 1, 2009. He became our President on October 1, 2009, and assumed the role of President and Chief Executive Officer on January 1, 2010. He","filed_date":"2015-04-01","accession":"0001079973-15-000232","full_text":"https://origin.rootz.global/static/filing/0001079973-15-000232.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":88,"match_count":11,"context":"Wayne Willkomm |  |  49 |  |  Non-Management Director |  | |  |  |  |  |  |  | (1) Member of the Audit Committee 2 Barry R. Knott joined the Company on February 1, 2009 as our Marketing Director, was appointed to our board of directors on June 11, 2009 and became Chief Operating Officer on July 1, 2009.He became our President on October 1, 2009, and assumed the role of President and Chief Executive Officer on January 1, 2010.He ha","filed_date":"2012-04-17","accession":"0001079973-12-000283","full_text":"https://origin.rootz.global/static/filing/0001079973-12-000283.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":80,"match_count":10,"context":"ld E. Siecke(1) |  |  79 |  |  Non-Management Director |  | |  Michael J. Kornelsen, D.M.A.(1) |  |  58 |  |  Non-Management Director |  | (1) Member of the Audit Committee Wayne Willkomm, Ph.D., was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2019-03-26","accession":"0001079973-19-000168","full_text":"https://origin.rootz.global/static/filing/0001079973-19-000168.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":80,"match_count":5,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2019-03-18","accession":"0001079973-19-000151","full_text":"https://origin.rootz.global/static/filing/0001079973-19-000151.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":80,"match_count":10,"context":"onald E. Siecke(1) |  |  78 |  |  Non-Management Director |  | |  Michael J. Kornelsen, D.M.A. |  |  57 |  |  Non-Management Director |  | (1) Member of the Audit Committee Wayne Willkomm, Ph.D., was elected as a director on July 5, 2011 to fill the vacancy that occurred on June 18, 2011 as a result of the death of Alan C. Castrodale. On January 18, 2016 he was designated as the President and Chief Executive Officer.","filed_date":"2018-04-05","accession":"0001079973-18-000236","full_text":"https://origin.rootz.global/static/filing/0001079973-18-000236.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"CURRENT ASSETS: |  |  (Unaudited) |  |  |  2012 |  |  | |  Cash |  |  $ |  2,835,657 |  |  |  $ |  2,338,012 |  |  | |  Accounts receivable, net |  |  |  745,967 |  |  |  |  405,321 |  |  | |  Installment receivables |  |  |  3,409 |  |  |  |  - |  |  | |  Inventories, net |  |  |  886,959 |  |  |  |  832,670 |  |  | |  Income taxes receivable |  |  |  113,651 |  |  |  |  174,129 |  |  | |  Deferre","filed_date":"2013-11-12","accession":"0001079973-13-000662","full_text":"https://origin.rootz.global/static/filing/0001079973-13-000662.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"CURRENT ASSETS: |  |  (Unaudited) |  |  |  2012 |  |  | |  Cash |  |  $ |  2,502,693 |  |  |  $ |  2,338,012 |  |  | |  Accounts receivable, net |  |  |  798,788 |  |  |  |  405,321 |  |  | |  Installment receivables |  |  |  1,032 |  |  |  |  - |  |  | |  Inventories, net |  |  |  1,008,593 |  |  |  |  832,670 |  |  | |  Income taxes receivable |  |  |  20,041 |  |  |  |  174,129 |  |  | |  Deferr","filed_date":"2013-08-12","accession":"0001079973-13-000480","full_text":"https://origin.rootz.global/static/filing/0001079973-13-000480.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":56,"match_count":7,"context":"ives best efforts to assist the Company in identifying and preventing any use or disclosure of the Confidential Information contrary to this Agreement. 9.4Executive represents and warrants that, upon separation of employment, and without any request by the Company, Executive will return to Company any and all property, documents, and files (including all recorded media, such as papers, computer disks or other","filed_date":"2017-10-10","accession":"0001079973-17-000580","full_text":"https://origin.rootz.global/static/filing/0001079973-17-000580.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"strategic_event","strength":48,"match_count":6,"context":"losed or otherwise made or communicated to the Company or the Company Board, and not withdrawn and (2) within 12 months following the date of such termination of this Agreement the Company shall have entered into a definitive agreement with respect to any Company Takeover Proposal, or consummated any Company Takeover Proposal (in each case, whether or not such Company Takeover Proposal is the same as the original Company Takeover P","filed_date":"2025-10-15","accession":"0001079973-25-001607","full_text":"https://origin.rootz.global/static/filing/0001079973-25-001607.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":48,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2018-03-26","accession":"0001079973-18-000196","full_text":"https://origin.rootz.global/static/filing/0001079973-18-000196.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":48,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows.Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional c","filed_date":"2017-03-27","accession":"0001079973-17-000193","full_text":"https://origin.rootz.global/static/filing/0001079973-17-000193.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":48,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows.Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional c","filed_date":"2016-03-22","accession":"0001079973-16-000865","full_text":"https://origin.rootz.global/static/filing/0001079973-16-000865.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":48,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows.Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional c","filed_date":"2015-03-20","accession":"0001079973-15-000210","full_text":"https://origin.rootz.global/static/filing/0001079973-15-000210.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":46,"match_count":2,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows.Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional c","filed_date":"2014-03-18","accession":"0001079973-14-000199","full_text":"https://origin.rootz.global/static/filing/0001079973-14-000199.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":43,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow neutral, additional cap","filed_date":"2012-03-16","accession":"0001079973-12-000150","full_text":"https://origin.rootz.global/static/filing/0001079973-12-000150.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":43,"match_count":1,"context":"nt to fund our operations for at least the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2010-11-09","accession":"0001079973-10-001181","full_text":"https://origin.rootz.global/static/filing/0001079973-10-001181.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":43,"match_count":1,"context":"nt to fund our operations for at least the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2010-06-21","accession":"0001079973-10-000707","full_text":"https://origin.rootz.global/static/filing/0001079973-10-000707.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"ai_adoption","strength":40,"match_count":5,"context":"over 2009 is attributable, in part ($80,000), to the Technology Transfer Agreementpertaining to the development and in-house manufacture of a component of our product.We expect to pay the final installment under this Technology Transfer Agreement of $40,000 in the fourth quarter of 2010.Future capital equipment expenditures will depend on future sales and success of on-going research and development","filed_date":"2010-11-09","accession":"0001079973-10-001181","full_text":"https://origin.rootz.global/static/filing/0001079973-10-001181.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":38,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows.Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional c","filed_date":"2013-03-15","accession":"0001079973-13-000180","full_text":"https://origin.rootz.global/static/filing/0001079973-13-000180.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"platform_shift","strength":33,"match_count":1,"context":"h and Development We believe that our future success depends to a large degree on our ability to conceive and develop new alcohol detection and measurement products and related services that (1) open new markets to Lifeloc, (2) enhance the performance of our currentproducts and (3) lower our costs or otherwise improve our methods of manufacture. Accordingly, we expect to continue to invest in research and d","filed_date":"2010-11-09","accession":"0001079973-10-001181","full_text":"https://origin.rootz.global/static/filing/0001079973-10-001181.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"margin_pressure","strength":32,"match_count":4,"context":"ago. This decrease results from the absence of several larger orders in the current period that may have reflected customers availability of funds in the previous period. In addition, the continuing inflationary pressure outlook on customers budgets may also have played a role.When royalties of $19,800 and rental income of $8,316 are included, total revenues of $2,219,376 decreased by $167,954, or 7%, for the three m","filed_date":"2025-08-11","accession":"0001079973-25-001237","full_text":"https://origin.rootz.global/static/filing/0001079973-25-001237.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":32,"match_count":4,"context":"n light of the board of directors risk assessment and management responsibilities. We do not believe we have any compensation policies and programs that give rise to risks reasonably likely to have a material adverse effect on us. **Audit Committee** Our board of directors maintains an audit committee comprised of two of our non-employee directors. The audit committee oversees our independent auditors and financial proc","filed_date":"2025-04-18","accession":"0001079973-25-000678","full_text":"https://origin.rootz.global/static/filing/0001079973-25-000678.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"margin_pressure","strength":32,"match_count":4,"context":"and our customers' continued demand for our products and services; | | |  |  our customers' inventory levels, and levels of demand for our customers' products and services; and | | |  |  competitive pricing pressures. | | We may not be able to grow or sustain revenues or achieve or maintain profitability on a quarterly or annual basis, and levels of revenue and/or profitability may vary from one such period to a","filed_date":"2025-03-28","accession":"0001079973-25-000507","full_text":"https://origin.rootz.global/static/filing/0001079973-25-000507.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":32,"match_count":4,"context":"n light of the board of directors risk assessment and management responsibilities. We do not believe we have any compensation policies and programs that give rise to risks reasonably likely to have a material adverse effect on us. **Audit Committee** Our board of directors maintains an audit committee comprised of two of our non-employee directors. The audit committee oversees our independent auditors and financial proc","filed_date":"2024-04-24","accession":"0001079973-24-000587","full_text":"https://origin.rootz.global/static/filing/0001079973-24-000587.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"ai_adoption","strength":32,"match_count":4,"context":"term portion | |  $ | 662,901 | | | Term Loans Payable. The term loan payable to UMB (formerly Citywide Banks) is secured by a first mortgage on our building and is payable in 119 equal monthly installments of $7,453 commencing October 30 2021, including principal and interest at 2.95% based on a 360 day year, plus a final payment of $773,727 (excluding interest) on September 30, 2031. Our minimum f","filed_date":"2026-08-14","accession":"0001079973-26-001088","full_text":"https://origin.rootz.global/static/filing/0001079973-26-001088.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_concentration","strength":29,"match_count":3,"context":"alifornia, Colorado, Michigan, Idaho, Texas and Nevada). Loss of this business, or delays or cancellations in purchasing by these states, seriously impacts our law enforcement business. **We derive a significant portion of our revenue directly or indirectly from government customers, and our business may be adversely affected by changes in the contracting or fiscal policies of those governmental entities.** We derive a significant","filed_date":"2025-03-28","accession":"0001079973-25-000507","full_text":"https://origin.rootz.global/static/filing/0001079973-25-000507.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":28,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan.If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2021-08-05","accession":"0001079973-21-000691","full_text":"https://origin.rootz.global/static/filing/0001079973-21-000691.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":28,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan. If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in returning to profitability and positive cash flow, additional capital may be requ","filed_date":"2020-11-13","accession":"0001079973-20-000966","full_text":"https://origin.rootz.global/static/filing/0001079973-20-000966.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":28,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan. If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2020-08-13","accession":"0001079973-20-000677","full_text":"https://origin.rootz.global/static/filing/0001079973-20-000677.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"LCTC","company":"Lifeloc Technologies, Inc","exchange":"OTC","sector":"Laboratory Analytical Instruments","signal_type":"risk_factor","strength":28,"match_count":1,"context":"sufficient to fund our operations for the next twelve months under our current operating plan. If we are unable to manage the business operations in line with our budget expectations, it could have a material adverse effect on business viability, financial position, results of operations and cash flows. Further, if we are not successful in sustaining profitability and remaining at least cash flow break-even, additional","filed_date":"2020-07-08","accession":"0001079973-20-000580","full_text":"https://origin.rootz.global/static/filing/0001079973-20-000580.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"b2dfcbaeb048cf2171882b25c3acec1bec5f8fdb2bd575b629bba7fb67765aa9","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"8aad9edc1bc33a2e9e0dc07678368bb1f4995de0e2da186a36483e2c7ad7b4db","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":17,"hourly_limit":500,"remaining":483,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}